Literature DB >> 25764248

Results of an open-access lung cancer screening program with low-dose computed tomography: the Gdańsk experience.

Witold Rzyman, Robert Dziedzic, Małgorzata Jelitto-Górska, Iwona Biadacz, Janina Książek, Janusz Siebert, Tomasz Zdrojewski, Michał Studniarek.   

Abstract

INTRODUCTION: Lung cancer screening with low-dose computed tomography (LDCT) is one of the most promising tools for reducing mortality from lung cancer.
OBJECTIVES: The aim of the study was to evaluate the results of an open-access lung cancer screening program with LDCT. PATIENTS AND METHODS: In total, 8649 asymptomatic volunteers between 50 and 75 years of age with a smoking history of at least 20 pack-years underwent LDCT screening. The presence of lung nodules with a diameter of less than 5 mm required a follow-up control visit after 12 months, and with a diameter of 5 to 10 mm--after 3, 6, and 12 months. Patients with a nodule of more than 10 mm in diameter required further diagnostic workup.
RESULTS: Lung nodules were detected in 4694 individuals (54%). Lung cancer was diagnosed in 107 patients (1.24%). Of 8649 participants, 300 (3.5%) were referred for further diagnostic workup, and 125 (1.5%) underwent surgical resection (81 because of malignant lesions; 44, benign lesions). Eighty-one participants (75%) underwent surgery with a curative intent, and 26 participants underwent oncological treatment. There were no perioperative deaths. The majority of surgical patients underwent lobectomy (video-assisted, in 30 patients; and open, in 38 patients). Stage I non-small cell lung cancer was detected in 64 of the surgical patients (79%).
CONCLUSIONS: The detection rate of lung cancer in the screening program with low-dose computed tomography is relatively low but patients were diagnosed at a very early stage of the disease compared with standard clinical practice.

Entities:  

Mesh:

Year:  2015        PMID: 25764248     DOI: 10.20452/pamw.2778

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  6 in total

1.  Non-calcified pulmonary nodules detected in low-dose computed tomography lung cancer screening programs can be potential precursors of malignancy.

Authors:  Robert Dziedzic; Witold Rzyman
Journal:  Quant Imaging Med Surg       Date:  2020-05

2.  Screen-detected multiple primary lung cancers in the ITALUNG trial.

Authors:  Mario Mascalchi; Camilla E Comin; Elena Bertelli; Lapo Sali; Cristina Maddau; Stefania Zuccherelli; Giulia Picozzi; Laura Carrozzi; Michela Grazzini; Gabriella Fontanini; Luca Voltolini; Alessandra Vella; Francesca Castiglione; Francesca Carozzi; Eugenio Paci; Maurizio Zompatori; Andrea Lopes Pegna; Fabio Falaschi
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 3.  Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis.

Authors:  Zixing Wang; Yaoda Hu; Yuyan Wang; Wei Han; Lei Wang; Fang Xue; Xin Sui; Wei Song; Ruihong Shi; Jingmei Jiang
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

4.  Performance of various risk prediction models in a large lung cancer screening cohort in Gdańsk, Poland-a comparative study.

Authors:  Marcin Ostrowski; Franciszek Bińczyk; Tomasz Marjański; Robert Dziedzic; Sylwia Pisiak; Sylwia Małgorzewicz; Mariusz Adamek; Joanna Polańska; Witold Rzyman
Journal:  Transl Lung Cancer Res       Date:  2021-02

5.  Lung cancers and pulmonary nodules detected by computed tomography scan: a population-level analysis of screening cohorts.

Authors:  Caichen Li; Jing Liao; Bo Cheng; Jianfu Li; Hengrui Liang; Yu Jiang; Zixuan Su; Shan Xiong; Feng Zhu; Yi Zhao; Ran Zhong; Feng Li; Jianxing He; Wenhua Liang
Journal:  Ann Transl Med       Date:  2021-03

Review 6.  A narrative review of invasive diagnostics and treatment of early lung cancer.

Authors:  Robert Dziedzic; Tomasz Marjański; Witold Rzyman
Journal:  Transl Lung Cancer Res       Date:  2021-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.